A panel of outside advisers to the U.S. Food and Drug Administration is expected to endorse emergency use of Moderna Inc.’s coronavirus vaccine during a meeting on Thursday, as the nation prepares to roll out a second vaccine.
Moderna vaccine trial data debated at U.S. hearing before expected authorization
